Y-Intercept (HK)’s United Therapeutics UTHR Stock Holding History

Y-Intercept (HK)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.73M	Buy	+14,271	New	+$8.04M	0.15%	154
2025 Q3	–	Sell	-17,315	Closed	-$4.98M	–	2075
2025 Q2	$4.98M	Buy	17,315 +13,160	+317%	+$3.93M	0.12%	221
2025 Q1	$1.28M	Sell	4,155 -2,015	-33%	-$691K	0.09%	322
2024 Q4	$2.18M	Buy	+6,170	New	+$2.27M	0.15%	185
2024 Q1	–	Sell	-7,344	Closed	-$1.61M	–	1783
2023 Q4	$1.61M	Buy	7,344 +5,927	+418%	+$1.37M	0.15%	184
2023 Q3	$320K	Buy	+1,417	New	+$326K	0.03%	739
2023 Q2	–	Sell	-2,195	Closed	-$492K	–	1743
2023 Q1	$492K	Buy	+2,195	New	+$541K	0.06%	540
2022 Q1	–	Sell	-3,372	Closed	-$729K	–	974
2021 Q4	$729K	Sell	3,372 -591	-15%	-$116K	0.17%	173
2021 Q3	$731K	Buy	3,963 +1,738	+78%	+$342K	0.13%	243
2021 Q2	$399K	Buy	+2,225	New	+$424K	0.1%	326

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Y-Intercept (HK)'s UTHR Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in United Therapeutics (UTHR) in Q2 2026: 14,271 shares worth $7.73M. The stake represents 0.15% of the portfolio and ranks #154 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in UTHR as recently as Q2 2025.

Y-Intercept (HK) first reported a position in UTHR in Q2 2021 and has held it in 10 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Y-Intercept (HK) held 14,271 shares of United Therapeutics worth $7.73M as of Q2 2026.
United Therapeutics was a new Y-Intercept (HK) position in Q2 2026.
United Therapeutics made up 0.15% of Y-Intercept (HK)'s portfolio in Q2 2026, its #154 holding.
Y-Intercept (HK) first reported a position in United Therapeutics in Q2 2021 and has held it in 10 quarters since.
880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.